Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$0.82

Avg closing price
Price range

12 Ken Griffin Neoleukin Therapeutics Trades

The first Neoleukin Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares five more times and sold shares on six occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Neoleukin Therapeutics anymore.

Avg closing price
Price range
Sold -2.39 Thousand shares Q3 2023
Avg closing price $0.99
Price range $0.62 - $4.03
New holding (+2.39 Thousand shares) Q2 2023
Avg closing price $0.82
Price range $0.68 - $0.91
Sold -3.98 Thousand shares Q3 2022
Avg closing price $1.02
Price range $0.63 - $1.33
Increased shares by 290.9% (+2.96 Thousand shares) Q2 2022
Avg closing price $1.22
Price range $0.92 - $2.25
Increased shares by 17.8% (+154 shares) Q1 2022
Avg closing price $2.92
Price range $1.72 - $5.23
Sold 22.7% shares (-254 shares) Q4 2021
Avg closing price $6.09
Price range $4.65 - $7.75
Increased shares by 111.7% (+590 shares) Q3 2021
Avg closing price $7.66
Price range $6.05 - $9.66
Sold 12.0% shares (-72 shares) Q2 2021
Avg closing price $11.06
Price range $9.23 - $13.12
Sold 96.7% shares (-17.6 Thousand shares) Q1 2021
Avg closing price $12.78
Price range $11.26 - $15.78
Increased shares by 591.8% (+15.6 Thousand shares) Q3 2020
Avg closing price $12.11
Price range $9.68 - $17.01
Sold 42.1% shares (-1.92 Thousand shares) Q2 2020
Avg closing price $13.03
Price range $9.95 - $17.05
New holding (+4.56 Thousand shares) Q1 2020
Avg closing price $10.29
Price range $6.12 - $13.64

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!